LN4691749
Ravuconazole , ≥98% , 170864-29-6
CAS NO.：170864-29-6
Empirical Formula: C22H17F2N5OS
Molecular Weight: 437.47
MDL number: MFCD09837767
| Pack Size | Price | Stock | Quantity |
| 1mg | RMB488.00 | In Stock |
|
| 5mg | RMB856.00 | In Stock |
|
| 10mg | RMB1504.00 | In Stock |
|
| 25mg | RMB3176.00 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 148-151°C |
| storage temp. | -20°C Freezer |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| form | Solid |
| color | Off-White |
Description and Uses
Ravuconazole belongs to a group of ‘‘second generation’’ triazoles; developed to overcome limitations, drug resistance, and drug interactions of the earlier triazoles. Formerly BMS-207147 and ER-30346, it was discovered by Eisai Co. Ltd. in Japan, developed by Bristol-Myers Squibb, and is now held again by Eisai. It is structurally related to fluconazole and voriconazole but, like isavuconazole, has a long half-life.
Ergosterol biosynthesis inhibitor. Antifungal.
